Cholesterol induces cardiac hypertrophy by activating the AKT pathway

Journal of Steroid Biochemistry and Molecular Biology

Volumn 138, Issue , 2013, Pages 307-313

  Lee, Hyunjung ^a,b   Yoo, Young Sook ^a   Lee, Daekee ^b   Song, Eun Joo ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

AKT; Cardiac hypertrophy; Cholesterol; H9c2 cells

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CHOLESTEROL; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN HEAVY CHAIN BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CELL SIZE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; PATHOGENESIS; UPREGULATION;

AKT; CARDIAC HYPERTROPHY; CHOLESTEROL; ERK; EXTRACELLULAR SIGNAL-REGULATED KINASE; G-PROTEIN-COUPLED RECEPTOR; GPCR; GSK3Β; H9C2 CELLS; IGF; INSULIN GROWTH FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; MAPK; MITOGEN-ACTIVATED PROTEIN KINASE; MTOR; PHOSPHATIDYLINOSITOL-3-KINASE; PHOSPHO-GLYCOGEN SYNTHASE KINASE-3Β; PI3K;

BLOTTING, WESTERN; CARDIOMEGALY; CELL LINE; CELL SURVIVAL; CHOLESTEROL; HUMANS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84881490372     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2013.07.008     Document Type: Article

References (25)

1. D.J. Glenn, D. Rahmutula, M. Nishimoto, F. Liang, and D.G. Gardner Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism Cardiovascular Research 84 2009 209 217
2. S. Usui, I. Yeh, B. Tian, and J. Sadoshima Global changes in gene expression during cardiac hypertrophy: a new direction of cardiac signaling research Journal of Molecular and Cellular Cardiology 41 2006 219 222 (Pubitemid 44088654)
3. J. Heineke, and J.D. Molkentin Regulation of cardiac hypertrophy by intracellular signalling pathways Nature Reviews Molecular Cell Biology 7 2006 589 600 (Pubitemid 44325350)
4. H.M. Hong, E.J. Song, E. Oh, M.H. Kabir, and C. Lee Endothelin-1- and isoproterenol-induced differential protein expression and signaling pathway in HL-1 cardiomyocytes Proteomics 11 2011 283 297
5. R. Meng, Z. Pei, A. Zhang, Y. Zhou, and X. Cai AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway Archives of Biochemistry and Biophysics 511 2011 1 7
6. W. Zhang, N. Yano, M. Deng, Q. Mao, and S.K. Shaw β-Adrenergic receptor-PI3K signaling crosstalk in mouse heart: elucidation of immediate downstream signaling cascades PLoS One 6 2011 e26581
7. Y.D. Paila, and A. Chattopadhyay Membrane cholesterol in the function and organization of G-protein coupled receptors Subcellular Biochemistry 51 2010 439 466
8. K.E. Porter, and N.A. Turner Statins and myocardial remodelling: cell and molecular pathways Expert Reviews in Molecular Medicine 13 2011 e22
9. W.G. Guo, F.F. Su, L.J. Yuan, G.D. Yang, and X.Q. Shi Simvastatin inhibits angiotensin II-induced cardiac cell hypertrophy: role of Homer 1a Clinical and Experimental Pharmacology and Physiology 37 2010 40 45
10. J.G. Shanes, K.N. Minadeo, A. Moret, M. Groner, and S.A. Tabaie Statin therapy in heart failure: prognostic effects and potential mechanisms American Heart Journal 154 2007 617 623 (Pubitemid 47432875)
11. C. Indolfi, E. Di Lorenzo, C. Perrino, A.M. Stingone, and A. Curcio Hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin prevents cardiac hypertrophy induced by pressure overload and inhibits p21ras activation Circulation 106 2002 2118 2124 (Pubitemid 35192819)
12. J.D. Luo, F. Xie, W.W. Zhang, X.D. Ma, and J.X. Guan Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes British Journal of Pharmacology 132 2001 159 164 (Pubitemid 32128445)
13. H. Takahashi, Y. Takeishi, T. Arimoto, T. Shishido, and T. Konta Pitavastatin inhibits cardiac hypertrophy in a rat model of progressive renal injury Journal of Cardiovascular Pharmacology 46 2005 487 493 (Pubitemid 41407578)
14. H.J. Jung, W.Y. Lee, Y.S. Yoo, B.C. Chung, and M.H. Choi Database-dependent metabolite profiling focused on steroid and fatty acid derivatives using high-temperature gas chromatography-mass spectrometry Clinica Chimica Acta 411 2010 818 824
15. H.P. Glazer, R.M. Osipov, R.T. Clements, F.W. Sellke, and C. Bianchi Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling Cell Cycle 8 2009 1738 1746
16. Y.D. Paila, E. Jindal, S.K. Goswami, and A. Chattopadhyay Cholesterol depletion enhances adrenergic signaling in cardiac myocytes Biochimica et Biophysica Acta 1808 2011 461 465
17. X. Kedi, Y. Ming, W. Yongping, Y. Yi, and Z. Xiaoxiang Free cholesterol overloading induced smooth muscle cells death and activated both ER- and mitochondrial-dependent death pathway Atherosclerosis 207 2009 123 130
18. J.X. Rong, M. Shapiro, E. Trogan, and E.A. Fisher Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading Proceedings of the National Academy of Sciences of the United States of America 100 2003 13531 13536 (Pubitemid 37444776)
19. D. Harzheim, M. Movassagh, R.S. Foo, O. Ritter, and A. Tashfeen Increased InsP3Rs in the junctional sarcoplasmic reticulum augment Ca2+ transients and arrhythmias associated with cardiac hypertrophy Proceedings of the National Academy of Sciences of the United States of America 106 2009 11406 11411
20. G. Condorelli, A. Drusco, G. Stassi, A. Bellacosa, and R. Roncarati AKT induces enhanced myocardial contractility and cell size in vivo in transgenic mice Proceedings of the National Academy of Sciences of the United States of America 99 2002 12333 12338
21. C.F. Clemente, J. Xavier-Neto, A.P. Dalla Costa, S.R. Consonni, and J.E. Antunes Focal adhesion kinase governs cardiac concentric hypertrophic growth by activating the AKT and mTOR pathways Journal of Molecular and Cellular Cardiology 52 2012 493 501
22. L. Yan, X. Wei, Q.Z. Tang, J. Feng, and Y. Zhang Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling Cardiovascular Research 92 2011 85 94
23. J. Wohlschlaeger, K.J. Schmitz, J. Palatty, A. Takeda, and N. Takeda Roles of cyclooxygenase-2 and phosphorylated Akt (Thr308) in cardiac hypertrophy regression mediated by left-ventricular unloading Journal of Thoracic and Cardiovascular Surgery 133 2007 37 43 (Pubitemid 46014222)
24. C. Ruppert, K. Deiss, S. Herrmann, M. Vidal, and M. Oezkur Interference with ERKThr188 phosphorylation impairs pathological but not physiological cardiac hypertrophy Proceedings of the National Academy of Sciences of the United States of America 110 18 2013 7440 7445
25. N.H. Purcell, B.J. Wilkins, A. York, M.K. Saba-El-Leil, and S. Meloche Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo Proceedings of the National Academy of Sciences of the United States of America 104 35 2007 14074 14079 (Pubitemid 350003337)